Argan Oil

1. INCI & CAS

INCI: Argan Oil · CAS: pending supplier / regulatory confirmation for the selected grade

2. Role in the formula

Argan Oil is carried as a named cosmetic ingredient for this SKU. Identity, assay and impurities are confirmed on the supplier TDS and COA. This page does not invent a CAS or a drug effect.

3. Typical use levels (formulation guide)

• Follow the supplier TDS for the finished formula's use range.

Use the supplier TDS for solvent, temperature and pH.

4. Regulatory sources & global compliance

• A CosIng entry naming Argan Oil does not by itself approve the purchased grade or complete cosmetic.
• Before EU placement, Regulation (EC) No 1223/2009 requires the completed product containing Argan Oil to receive its own safety assessment for the completed formula, not simply for an ingredient in isolation.
• Check the supplier's technical information for the Argan Oil grade and confirm the relevant market filing list.

5. Safety & risk assessment

The percentage is shown for cosmetic development; it is not evidence of drug approval or OTC authorization with patch and stability testing still needed for the completed formula.

6. Stability & packaging

Keep the ingredient in cool, closed bulk storage away from sunlight; evaluate packaging against the formula's susceptibility to oxidation; then verify formula stability and pack compatibility on the confirmed batch.

7. Claims language (Do / Don’t)

• Names Argan Oil as a cosmetic ingredient on this SKU

• This ingredient reference does not support a drug effect, a clinical cure, or certification status not established for the SKU.
• The formulation record for Argan Oil should not be used to substantiate whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI & CAS

INCI: Caprylic/Capric Triglyceride · CAS: 73398-61-5

2. Role in the formula

For light-oil use in lotions, balms, and cleansing oils, the reference lists caprylic/capric triglyceride.

3. Typical use levels (formulation guide)

• For lotions, the reference gives 3–8%.
• For cleansing oils and balms, use 20–60% in this reference.

Route Caprylic/Capric Triglyceride through the oil phase.

4. Regulatory sources & global compliance

• The CosIng record for Caprylic/Capric Triglyceride, where listed, is informational rather than product-specific authorization.
• An EU-market cosmetic under Regulation (EC) No 1223/2009 requires an assessment of the safety of the final cosmetic containing Caprylic/Capric Triglyceride for the completed formula, not simply for an ingredient in isolation.
• Review the supplier TDS for the received Caprylic/Capric Triglyceride grade, together with the target market's current filing requirements.

5. Safety & risk assessment

This formulation note gives a cosmetic-use reference level; no drug approval or OTC-monograph status follows from this guide so assess patch response and stability in the final formula.

6. Stability & packaging

Store sealed bulk away from heat and sunlight; where oxidation is a concern, evaluate airless or pump packaging; then verify formula stability and pack compatibility on the confirmed batch.

7. Claims language (Do / Don’t)

• The recorded cosmetic positioning for Caprylic/Capric Triglyceride highlights light-triglyceride.

• This cosmetic guide does not support claims of drug action or cure, or a product certification outside the supporting records.
• The formulation record for Caprylic/Capric Triglyceride does not support skin whitening, acne treatment, antiperspirant use, sun protection, or hair growth.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

This reference identifies squalane as a stable hydrocarbon emollient and calls for a plant-derived grade, not mineral oil.

3. Typical use levels (formulation guide)

• For gel-creams, use 2–6% in this reference.
• The stated reference for dry oils is 10–30% in this reference.
• For balms, the recorded level is 5–15%.

The oil phase is the addition point for Squalane, with no high-shear wax operation.

4. Regulatory sources & global compliance

• Use CosIng's information on Squalane as a reference, then verify the specific grade and intended use under market rules.
• Regulation (EC) No 1223/2009 sets the requirement for a safety assessment of the finished cosmetic containing Squalane rather than for an ingredient name alone.
• Confirm the received Squalane grade against supplier documentation, then verify the intended market's filing requirements.

5. Safety & risk assessment

The stated concentration is a cosmetic-development reference; this reference is not approval for drug use or OTC marketing and the finished formula still needs patch and stability testing.

6. Stability & packaging

Protect sealed bulk from warmth and direct light; where appropriate, assess an airless or pump pack for oxidation-sensitive systems; follow with stability and packaging checks on the confirmed batch.

7. Claims language (Do / Don’t)

• This guide frames Squalane's cosmetic direction around a light-emollient role.

• The ingredient guidance does not substantiate drug effects, clinical cures, or unsupported product certifications.
• This guide to Squalane provides no basis for whitening effects, acne treatment, antiperspirant performance, sunscreen protection, or hair growth.